The endocrine influence on the bone microenvironment in early breast cancer

Abstract

Multiple factors influence the survival of disseminated breast tumour cells (DTCs) in bone. Whereas gene signature studies have identified genes that predict a propensity of tumours to metastasise to bone, the bone environment is key in determining the fate of these tumour cells. Breast cancer cells locate to specific niches within the bone that support their survival, regulated by host factors within the bone microenvironment including bone cells, cells of the bone micro vasculature, immune cells and the extracellular matrix. Reproductive endocrine hormones that affect bone and clinical studies across the menopausal transition have provided comprehensive understanding of the changes in the bone microenvironment during this time. Menopause is characterized by a decrease in ovarian oestradiol and inhibins, with an increase in pituitary follicle-stimulating hormone and this review will focus on the role of these three hormones in determining the fate of DTCs in bone. Both in vivo and clinical data suggest that premenopausal bone is a conducive environment for growth of breast cancer cells in bone. Adjuvant cancer treatment aims to reduce the risk of tumour recurrence by affecting DTCs. Drugs targeting the bone resorbing osteoclasts, such as bisphosphonates, have therefore been evaluated in this setting. Both preclinical and adjuvant clinical studies have shown that bisphosphonates' ability to decrease tumour growth in bone is influenced by the levels of endocrine hormones, with enhanced effects in a postmenopausal bone microenvironment. The challenge is to understand the molecular mechanisms behind this phenomenon and to evaluate if alternative adjuvant bone-targeted therapies may be effective in premenopausal women.

The Role of Tumor Microenvironment in Chemoresistance: 3D Extracellular Matrices as Accomplices

“…It has now been established that the tumor microenvironment plays a huge role in determining the initiation and progression of cancer [ 9 , 11 , 14 , 38 , 72 , 75 , 76 , 77 , 88 , 92 , 93 ]. The tumor microenvironment is a dynamic and ever-changing environment comprised of many components including cancer cells, fibroblasts, immune cells, endothelial cells and the ECM [ 38 , 46 , 47 , 94 , 95 , 96 , 97 , 98 ]. Cancer-associated fibroblasts or tumor-associated fibroblasts (CAFs or TAFs) are the major cellular component of this environment and they play a role in modulating cancer progression [ 99 , 100 , 101 , 102 ].…”

The Application of Citrus folium in Breast Cancer and the Mechanism of Its Main Component Nobiletin: A Systematic Review

“…In addition, bone metastasis is related to the disharmony between nutritive qi and defensive qi. The ability of blood to nourish bones and defensive qi to resist exogenous pathogens decreases, causing BC cytokines to interact with cells in the bone microenvironment, thereby triggering bone metastasis [ 71 ].…”

Systematic Analysis of Survival-Associated Alternative Splicing Signatures in Thyroid Carcinoma

“…In addition, although metabolic changes in tumor cells may not be the main cause of tumor initiation, changes in the tumor microenvironment are conducive to the growth of tumor cells, which has very important clinical and basic research value ( 27 , 28 ). The group of AS events we identified exerts their biological functions in the energy metabolism of thyroid cancer.…”